1012 related articles for article (PubMed ID: 32226518)
21. Prognostic Value of N6-Methyladenosine-Related lncRNAs in Early-Stage Colorectal Cancer: Association With Immune Cell Infiltration and Chemotherapeutic Drug Sensitivity.
Xiong Z; Li X; Yin S; Xie M; Mao C; Zhang F; Chen H; Jin L; Lian L
Front Mol Biosci; 2021; 8():724889. PubMed ID: 34712696
[No Abstract] [Full Text] [Related]
22. Differential analysis of RNA methylation regulators in gastric cancer based on TCGA data set and construction of a prognostic model.
Li J; Zuo Z; Lai S; Zheng Z; Liu B; Wei Y; Han T
J Gastrointest Oncol; 2021 Aug; 12(4):1384-1397. PubMed ID: 34532096
[TBL] [Abstract][Full Text] [Related]
23. The methylation modification of m6A regulators contributes to the prognosis of ovarian cancer.
Zhu W; Zhao L; Kong B; Liu Y; Zou X; Han T; Shi Y
Ann Transl Med; 2022 Jan; 10(2):59. PubMed ID: 35282121
[TBL] [Abstract][Full Text] [Related]
24. N6-methyladenosine related gene expression signatures for predicting the overall survival and immune responses of patients with colorectal cancer.
Yu L; Wang L; Sun J; Zhou X; Hu Y; Hu L; He Y; Lin C; Chen J; Xu X; Dunlop MG; Theodoratou E; Ding K; Li X
Front Genet; 2023; 14():885930. PubMed ID: 36936424
[TBL] [Abstract][Full Text] [Related]
25. N6-Methyladenosine Regulators Promote Malignant Progression of Gastric Adenocarcinoma.
Zhao Y; Yan X; Wang Y; Zhou J; Yu Y
Front Oncol; 2021; 11():726018. PubMed ID: 35299934
[TBL] [Abstract][Full Text] [Related]
26. Analysis of Genetic Alteration Signatures and Prognostic Values of m6A Regulatory Genes in Head and Neck Squamous Cell Carcinoma.
Zhou X; Han J; Zhen X; Liu Y; Cui Z; Yue Z; Ding L; Xu S
Front Oncol; 2020; 10():718. PubMed ID: 32547941
[TBL] [Abstract][Full Text] [Related]
27. Identification of m6A methyltransferase-related genes predicts prognosis and immune infiltrates in head and neck squamous cell carcinoma.
Zhang Y; Li L; Ye Z; Zhang L; Yao N; Gai L
Ann Transl Med; 2021 Oct; 9(20):1554. PubMed ID: 34790760
[TBL] [Abstract][Full Text] [Related]
28. A five-gene signature derived from m6A regulators to improve prognosis prediction of neuroblastoma.
Wang Z; Cheng H; Xu H; Yu X; Sui D
Cancer Biomark; 2020; 28(3):275-284. PubMed ID: 32176634
[TBL] [Abstract][Full Text] [Related]
29. Expression profiles and prognostic significance of RNA N6-methyladenosine-related genes in patients with hepatocellular carcinoma: evidence from independent datasets.
Zhou Y; Yin Z; Hou B; Yu M; Chen R; Jin H; Jian Z
Cancer Manag Res; 2019; 11():3921-3931. PubMed ID: 31118805
[No Abstract] [Full Text] [Related]
30. m6A RNA methylation regulators play an important role in the prognosis of patients with testicular germ cell tumor.
Cong R; Ji C; Zhang J; Zhang Q; Zhou X; Yao L; Luan J; Meng X; Song N
Transl Androl Urol; 2021 Feb; 10(2):662-679. PubMed ID: 33718069
[TBL] [Abstract][Full Text] [Related]
31. Integrative proteomics and m6A microarray analyses of the signatures induced by METTL3 reveals prognostically significant in gastric cancer by affecting cellular metabolism.
Peng G; Chen S; Zheng N; Tang Y; Su X; Wang J; Dong R; Wu D; Hu M; Zhao Y; Liu M; Wu H
Front Oncol; 2022; 12():996329. PubMed ID: 36465351
[TBL] [Abstract][Full Text] [Related]
32. Construction and validation of prognostic prediction established on N6-methyladenosine related genes in cervical squamous cell carcinoma.
Chen D; Guo W; Yu H; Yang J
Transl Cancer Res; 2022 Sep; 11(9):3064-3079. PubMed ID: 36237271
[TBL] [Abstract][Full Text] [Related]
33. Construction and validation of a novel prognostic model for lung squamous cell cancer based on N6-methyladenosine-related genes.
Jia E; Ren N; Guo B; Cui Z; Zhang B; Xue J
World J Surg Oncol; 2022 Feb; 20(1):59. PubMed ID: 35220962
[TBL] [Abstract][Full Text] [Related]
34. Multiomics profile and prognostic gene signature of m6A regulators in uterine corpus endometrial carcinoma.
Wang Y; Ren F; Song Z; Wang X; Ma X
J Cancer; 2020; 11(21):6390-6401. PubMed ID: 33033522
[TBL] [Abstract][Full Text] [Related]
35. N6-methyladenosine methylation-related genes
Wang Y; Li T; Liu H; Liang Y; Wang G; Fu G; Takatsuki M; Qu H; Jing F; Li J; Jiang M
Ann Transl Med; 2022 Dec; 10(24):1398. PubMed ID: 36660669
[TBL] [Abstract][Full Text] [Related]
36. Expression patterns and prognostic value of m
Liu X; Liu L; Dong Z; Li J; Yu Y; Chen X; Ren F; Cui G; Sun R
Am J Transl Res; 2019; 11(7):3972-3991. PubMed ID: 31396313
[TBL] [Abstract][Full Text] [Related]
37. Establishment of a Risk Signature Based on m6A RNA Methylation Regulators That Predicts Poor Prognosis in Renal Cell Carcinoma.
Wei J; Qian Y; Tang Y; Ge X; Jiang K; Fang Y; Fu D; Kong X; Xiao Q; Ding K
Onco Targets Ther; 2021; 14():413-426. PubMed ID: 33488096
[TBL] [Abstract][Full Text] [Related]
38. FTO promotes gastric cancer progression by modulating MAP4K4 expression via demethylation in an m6A-dependent manner.
Yin Z; Guo X; Liang X; Wang Z
Med Oncol; 2024 Apr; 41(5):120. PubMed ID: 38643333
[TBL] [Abstract][Full Text] [Related]
39. m6A-related lncRNAs predict prognosis and indicate cell cycle in gastric cancer.
Wan D; He L; Guo C; Zhong Z; Yan X; Cao J; Xu Q; Zhang H; Duan B
Front Genet; 2023; 14():1140218. PubMed ID: 37408779
[No Abstract] [Full Text] [Related]
40. Characterization of the Prognostic m6A-Related lncRNA Signature in Gastric Cancer.
Wang H; Meng Q; Ma B
Front Oncol; 2021; 11():630260. PubMed ID: 33928026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
